Exelixis
EXEL
#1589
Rank
$13.81 B
Marketcap
$54.98
Share price
-2.03%
Change (1 day)
23.63%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company